1999 WHO/ISH Guidelines applied to a 1999 MONICA sample from northern Sweden

Journal of Hypertension

Volumn 20, Issue 1, 2002, Pages 29-35

  Persson, Mats ^a   Carlberg, Bo ^a   Mjörndal, Tom ^a   Asplund, Kjell ^a   Bohlin, Jens ^a   Lindholm, Lars ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Blood pressure; Guidelines; Hypertension; Risk stratification; Treatment goal

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN; TREATMENT INDICATION; WORLD HEALTH ORGANIZATION;

EID: 0036054603     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200201000-00006     Document Type: Article

References (28)

1. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension
2. Elevated systolic blood pressure and risk of cardiovascular and renal disease: Overview of evidence from observational epidemiological studies and randomised controlled trials
3. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
4. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease
5. Interpretation of prospective trials in hypertension: Do treatment guidelines accurately reflect current evidence?
6. Cardiovascular disease risk profiles
7. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
8. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 Years of follow-up in the Framingham study
9. High risks of cerebro-cardiovascular morbidity in well treated male hypertensives
10. Measurement of health outcome and associated costs in cardiovascular disease
11. Lifetime cost of stroke in the United States
12. Pharmacoeconomic considerations in the management of hypertension
13. Moderately elevated blood pressure
14. The Sixth Report of the Joint National Committee on prevention, detection, evaluation, and treatment, of high blood pressure
15. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification
16. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study
17. The World Health Organisation MONICA Project (monitoring trends and determinants in cardiovascular disease): A major international collaboration
18. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations
19. Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA project. An ecological study of 18 populations
20. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys
21. Fifteen years with clinical guidelines in the treatment of hypertension - Still discrepancies between intentions and practice
22. Prevention of coronary heart disease in clinical practice
23. Blood pressure management: Individualized treatment based on absolute risk and potential for benefit
24. The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study. Rationale, design, and methods
25. Cardiovascular risk stratification in hypertensive patients: Impact of echocardiography and carotid ultrasonography
26. Blood pressure screening, management and control in England: Result from the health survey for England 1994
27. Inadequate management of blood pressure in a hypertensive population